Zanamivir hydrate

• CAT Number: L016031
• CAS Number: 1260601-68-0
• Molecular Formula: C12H22N4O8
• Molecular Weight: 350.33
• Purity: ≥95%
• IUPAC Name: (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid;hydrate
• InChI: InChI=1S/C12H20N4O7.H2O/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17;/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16);1H2/t5-,6+,8+,9+,10+;/m0./s1
• InChIKey: OELRRAURPSTFEX-VCFRRRQNSA-N
• SMILES: CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N.O

Zanamivir hydrate（Cat No.:L016031）, is a pharmaceutical compound used to treat and prevent influenza A and B infections. It is a neuraminidase inhibitor, blocking the virus’s activity and reducing infection severity and duration. The term “hydrate” indicates the presence of water molecules in its crystal structure. As a prescribed medication, Zanamivir hydrate should be used as directed by healthcare professionals, following safety guidelines. Its effectiveness in inhibiting viral replication makes it valuable in managing influenza and its potential complications.